In laboratory studies, two doses of the vaccine stimulated the production of more neutralizing antibodies than an approved mRNA vaccine
Most Free COVID-19 Tests Have Shipped: White House
Last month, about 60 million orders for the free tests were received within 10 days after launching the initiative
COVID-19 Travel Rules to Europe May Be Lifted for Vaccinated
EU-authorized vaccines include those from Pfizer, Moderna, AstraZeneca, Johnson & Johnson, and Novavax
San Juan’s Unhealthy Mosquitoes
When considering a Caribbean destination for Spring Break 2022, calculating your ability to protect yourself from mosquito bites has become essential.
One of the Caribbean's favorite vacation cities is San Juan, Puerto Rico, which annually averages about 1.5 million visitors.
However, the local mosquitoes in San Juan continue carrying dengue and Zika viruses.
A recent Puerto Rico Department of Health Weekly Arboviral Diseases report indicates these viruses are infecting people in 2022.
Low Risk Seen for Second Allergic Reaction to mRNA COVID-19 Vaccine
Of 1,366 patients with immediate allergic reaction to first dose, six developed severe immediate allergic reaction after second dose
Boris Johnson Lifts Last COVID-19 Restrictions in England
Under the new plan, mandatory self-isolation and routine tracing of infected people’s contacts will end
Hepatitis A, the Other Vaccine-Preventable Outbreak
When discussing vaccine-preventable hepatitis A infections, many people think about contaminated food and water. However, in 2022, hepatitis A remains a common person-to-person spread virus.
And the risk for hepatitis A virus (HAV) transmission has continued during the COVID-19 pandemic.
Since hepatitis A outbreaks were first identified in 2016, thirty-seven U.S. states have publicly reported 43,705 cases and 420 related fatalities to the U.S. CDC as of February 11, 2022.
Furthermore, 22 states are reporting additional hepatitis A cases in 2022.
Malaria Prevention Includes Protective Sleeping
Since the 1990s, bed nets with insecticides have been an invaluable tool for malaria prevention, wrote Gretchen Vogel with Science.org on February 2, 2022.
While young children who sleep under these nets are far less likely to die of the disease, some scientists have worried this might increase the risk of contracting malaria later in life by preventing the development of natural immunity.
Now, an ambitious new study’s finding allays those fears.
Low-Dose Ivermectin Found Ineffective with High-Risk COVID-19 Patients
The peer-reviewed JAMA Network published a study today that found in a randomized clinical trial of high-risk patients with mild to moderate COVID-19, ivermectin treatment during early illness did not prevent progression to severe disease.
This study’s findings, published on February 18, 2022, do not support the use of low-dose ivermectin for COVID-19 patients at risk.
These 500 randomized COVID-19 patients received Ivermectin 0.4mg/kg of body weight/day for 5 days.